Predain Intelligence’s Post

𝗛𝗲𝗮𝗿𝘁 𝗳𝗮𝗶𝗹𝘂𝗿𝗲 𝗰𝗮𝗿𝗲 𝗷𝘂𝘀𝘁 𝗴𝗼𝘁 𝗮 𝗴𝗮𝗺𝗲-𝗰𝗵𝗮𝗻𝗴𝗶𝗻𝗴 𝘂𝗽𝗴𝗿𝗮𝗱𝗲 📢 Today marks a significant milestone as Johnson & Johnson MedTech announces its planned acquisition of V-Wave, a pioneer in heart failure treatment, for $600 million, with potential milestone payments reaching up to $1.1 billion. V-Wave’s Ventura Interatrial Shunt (IAS) is a groundbreaking, minimally invasive solution designed to bring hope to the 800,000 U.S. patients who battle heart failure with reduced ejection fraction (HFrEF) each year. By effectively reducing elevated left atrial pressure, this innovative device addresses a critical need in cardiovascular care. This acquisition not only strengthens J&J’s cardiovascular portfolio but also reaffirms its mission to deliver smarter, less invasive treatments. With an FDA Breakthrough Device Designation and CE mark already secured, the potential for the Ventura IAS to change lives is immense. For those in the medical device industry, this is a testament to the power of innovation and collaboration in addressing some of the most pressing healthcare challenges. Excited to see how V-Wave's cutting-edge technology will flourish as part of the J&J family! #MedTech #HealthcareInnovation #Cardiovascular #HeartFailure #JohnsonAndJohnson #VWAVE #MedicalDevices

Qsight Alpha Expands Coverage with the Inclusion of LeMaitre Vascular The newest addition to Qsight Alpha’s Medical Device coverage is LeMaitre Vascular (LMAT). This has been a commonly requested company, and we are excited to be providing insights across the company’s portfolio of peripheral vascular disease products. Looking at the past ten quarters, Qsight has consistently outperformed market expectations and provided accurate insights to drive informed decision-making. During this time, the mean absolute percentage error in Qsight’s projections has been 1.79% With Qsight’s Alpha Hospital Purchasing Data, you will gain visibility into the medical devices and supplies purchased by over 3,500 U.S. facilities. We offer sales projections for 32 publicly traded companies in the MedTech space – all to inform your strategies with predictive insights. Book a demo today: https://lnkd.in/ekEzm4Uu #PredictiveAnalytics #MarketInsights #BusinessForecasting #QsightAlpha

Our devices are trusted by leading institutions worldwide! We are extremely thankful to the institutions that have trusted in our tVNS® devices and have found groundbeaking results in research for using our device to alleviate symptoms of various conditions. For over two decades, our dedication to pioneering innovation has positioned us as leaders in non-invasive vagus nerve stimulation. Our extensive research and development, supported by robust clinical trials, guarantee the effectiveness, safety, and reliability of our devices! With Class IIa medical device approval under the EU-MDR, we provide scientifically validated solutions in a market saturated with unverified alternatives. Since the launch of the Cerbomed Nemos device, we've maintained our leadership in non-invasive vagus nerve technology, preferred by healthcare professionals and researchers worldwide for its unparalleled safety, reliability, and precision! Click the link in our bio to find out more about how our devices are revolutionising the medical industry! #tvns #vagusnerve #vagusnervestimulation #noninvasivetreatment #anxietytreatment

🌟 Exciting News from Endoron Medical! 🌟 We are thrilled to share that Endoron Medical has achieved a major milestone by expanding our reach to the United States with the acquisition of a new patent. 🌎 Our cutting-edge endostapling technology is set to revolutionize the landscape of Abdominal Aortic Aneurysm (AAA) treatment through EndoVascular Aneurysm Repair (EVAR). While EVAR already presents an operative mortality advantage over open repair, long-term survival benefits have often been elusive due to durability challenges with existing endografts. Enter Aortoseal - Endoron’s groundbreaking solution that not only offers patients a minimally invasive procedure but also ensures a sustained survival advantage, coupled with fewer complications and reinterventions. This achievement signifies a pivotal moment in our journey, emphasizing our commitment to innovation and our aspiration for a global impact. Join us in celebrating this step forward in advancing healthcare solutions for AAA patients worldwide! #EndoronMedical #InnovationInHealthcare #AAA #EVAR #GlobalHealthcareSolution #AAA  

Explore Opportunities in the Dynamic Pacemakers Market! The Pacemakers Market is projected to experience a robust growth of 3-4% by 2028, fueled by various factors such as the rising prevalence of cardiovascular diseases, increased demand for minimally invasive procedures, technological advancements in pacemaker technology, a growing aging population, and favorable reimbursement environments in key markets. 🌐 Key Market Players: Join industry leaders shaping the future! 🌟 Explore opportunities with companies at the forefront of innovation, including Boston Scientific, Cook Medical, GE HealthCare, ZOLL Medical Corporation, Medtronic, LivaNova, OSYPKA MEDICAL GmbH, BIOTRONIK, Lepu Medical Technology (Beijing) Co., Ltd., and Abbott. #HealthcareInnovation #Pacemakers #CardiovascularHealth #MedicalTechnology #ConnectWithExperts #IndustryInsights #HealthTechRevolution #CardioCare #MedicalInnovation #FutureOfHealthcare #InvasiveProcedures #TechAdvancements #MarketGrowth #HeartHealth #HealthcareTrends #IndustryLeadership #ConnectAndCollaborate #PacemakersInsights #MedTechLeaders #GlobalHealthcare #InnovationHub #HealthcareAnalytics #CardiovascularTech #ExpertConnect #MarketForecast #DigitalHealthWave

How is Inceptiv™ with closed-loop technology different? Melissa Murphy, MD, MPH explains, “with closed-loop we can have instant automatic adjustment from moment-to-moment based on the patient’s activity to provide a more consistent delivery of stimulation.” So, patients no longer have to think about it. Patients can feel confident they will be able to get MR imaging† if they need it, as well. As Krishnan Chakravarthy M.D., Ph.D puts it, “Medtronic stands far and above their competition in terms of consistency and access for their patients to the best quality MRI [conditional]† devices.” Watch the video to hear more from these pain intervention leaders about how the Inceptiv™ closed-loop system works and why these experts see this as a transformational moment in their field. See important safety information: https://bit.ly/3XyvjVh Learn more about closed-loop technology by going to Medtronic.com/Inceptiv or Medtronic Academy https://lnkd.in/eMpet5ck. Talk to your Medtronic Representative to learn more about Inceptiv™ SCS. #MDTPainInterventional #PatientFirst #InceptivSCS #ClosedLoopTechnology #MedtronicSCS #ClosedLoop #SCS #SpinalCordStimulation #ECAP #MRIAccess †Under specific conditions. Refer to product labeling for full list of conditions. Product usage represented may not be approved or cleared in all markets.

#Arrhythmia_Monitoring_Devices Market Key Players Analysis and Forecast To 2032 by Value Market Research >> https://shorturl.at/20jSE #Arrhythmia monitoring devices are #medical devices utilized to detect and monitor abnormal #heart rhythms, known as arrhythmias, in #patients. These devices are designed to continuously or intermittently #monitor the heart's #electrical activity through #electrodes attached to the patient's skin or implanted within the #body. These devices play an #integral role in diagnosing and managing various arrhythmias, including atrial #fibrillation, #ventricular tachycardia, and bradycardia, by providing real-time #data to healthcare providers for timely intervention and #treatment. AliveCor BioTelemetry, Inc. BIOTRONIK GE HealthCare iRhythm healthcare Medi-Lynx Cardiac Monitoring, LLC St. Jude Medical Medtronic Nihon Kohden America Nuubo Spacelabs Healthcare #arrhythmia #monitoringdevices #medicaldevices #healthcareindustry #pharmaceuticalindustry #healthcareresearch